Harvard Bioscience
HBIO
HBIO
72 hedge funds and large institutions have $116M invested in Harvard Bioscience in 2018 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.77% more ownership
Funds ownership: 63.59% → 65.35% (+1.8%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
72
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.01M | |
| 2 | +$1.66M | |
| 3 | +$1.34M | |
| 4 |
Millennium Management
New York
|
+$1.02M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$829K |
Top Sellers
| 1 | -$4.99M | |
| 2 | -$1.01M | |
| 3 | -$896K | |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$716K |
| 5 |
First Manhattan
New York
|
-$432K |